학술논문
A randomized double-blind controlled trial of everolimus in individuals with PTEN mutations: Study design and statistical considerations
Document Type
Article
Author
Source
In Contemporary Clinical Trials Communications March 2021 21
Subject
Language
ISSN
2451-8654